glp-1 news november 6 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Medicare $50 GLP-1 Weight Loss

Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists in older adults

[55] demonstrated that Cap exhibits anti-obesity effects by enhancing the mRNA expression of uncoupling protein 1 (UCP1) in WAT and upregulating proteins associated with thermogenesis, lipid metabolism, and energy transduction

Incidence of type II diabetes in chronic obstructive pulmonary disease: a nested case-control study

Although these results are highly promising, long-term data including primary CV prevention populations and utilizing other SGLT2-I will be needed to fully assess the CV outcomes with this class of medications

Diabetes 62 , 11311138 (2013)

You wont find any fad diets or miracle cures here just a solid nutritional foundation and great taste